Day One Biopharmaceuticals Inc. (DAWN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 2,114,006 | 0.57 | |
| ≡ | Viking Global Investors | Sell 100.00% | 2,558,563 | 0.13 | |
| Q3 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 74.55% | 902,868 | 0.24 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 3.62% | 45,432 | 0.01 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,256,570 | 0.40 | |
| Q2 2023 | |||||
| ≡ | Viking Global Investors | Add 64.16% | 1,000,000 | 0.05 | |
| Q3 2022 | |||||
| ≡ | Viking Global Investors | Reduce 16.09% | 298,861 | 0.03 | |
| Q2 2022 | |||||
| ≡ | Viking Global Investors | Add 60.48% | 700,000 | 0.06 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Reduce 4.46% | 53,972 | 0.00 | |
| Q3 2021 | |||||
| ≡ | Viking Global Investors | Reduce 9.69% | 130,000 | 0.01 | |
| Q2 2021 | |||||
| ≡ | Viking Global Investors | Buy | 1,341,396 | 0.09 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.